We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Surface Stimulation for Female Sexual Dysfunction

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02692417
Recruitment Status : Active, not recruiting
First Posted : February 26, 2016
Last Update Posted : January 8, 2018
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Female sexual dysfunction, including sexual arousal disorder, has a significant clinical impact, affecting millions of women in the United States alone. Peripheral nerve stimulation, such as posterior tibial nerve stimulation (PTNS) and dorsal genital nerve stimulation (DGNS) can modulate neural circuits for bladder and fecal continence. The investigators hypothesize that periodic DGNS and PTNS will modulate autonomic neural circuits and promote improvements in sexual function in women with sexual arousal disorder. Subjects will be randomized to receive one of the stimulation approaches. Subjects will have weekly 30-minute sessions across twelve weeks.

Condition or disease Intervention/treatment Phase
Female Sexual Dysfunction Device: Transcutaneous Electrical Nerve Stimulation Phase 1 Phase 2

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Surface Stimulation for Female Sexual Dysfunction
Study Start Date : February 2016
Estimated Primary Completion Date : February 2018
Estimated Study Completion Date : February 2018
Arms and Interventions

Arm Intervention/treatment
Experimental: Posterior Tibial Nerve Stimulation Group
Subjects in this group will have transcutaneous electrical nerve stimulation electrodes placed on the skin surface over their posterior tibial nerve, that is in the area of the ankle, and receive stimulation for 30 minutes in weekly sessions for 12 weeks.
Device: Transcutaneous Electrical Nerve Stimulation
Both arms will receive stimulation from the same TENS (transcutaneous electrical nerve stimulation) unit with identical stimulation frequency, but potentially different amplitudes depending on the subject's stimulation threshold.
Experimental: Dorsal Genital Nerve Stimulation Group
Subjects in this group will have transcutaneous electrical nerve stimulation electrodes placed on the skin surface over the dorsal genital nerve, that is above and/or on the lateral side of the clitoris, and receive stimulation for 30 minutes in weekly sessions for 12 weeks.
Device: Transcutaneous Electrical Nerve Stimulation
Both arms will receive stimulation from the same TENS (transcutaneous electrical nerve stimulation) unit with identical stimulation frequency, but potentially different amplitudes depending on the subject's stimulation threshold.


Outcome Measures

Primary Outcome Measures :
  1. Improvement in Female Sexual Function Index (FSFI) [ Time Frame: 6, 12, and 18 weeks after beginning of treatment ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Adult women ≥ 18 years of age
  • Sexually active ≥ 1 time per month (≥ 2 times per month preferred)
  • Score of 19 or less on a 6-question set of the Female Sexual Function Index (FSFI) survey
  • Neurologically stable
  • Ambulatory
  • Capable of giving informed consent
  • English speaking
  • Capable and willing to follow study procedures

Exclusion Criteria:

  • Men
  • Women ≤ 17 years of age
  • Pregnant or planning to get pregnant during the study period
  • Clinically diagnosed neurological bladder dysfunction
  • Prior experience with PTNS or DGNS
  • Current use of transcutaneous electrical nerve stimulation (TENS) on pelvis, back, or legs
  • Implanted pacemaker, defibrillator, spinal cord stimulator, or sacral root stimulator
  • Taking flibanserin
  • Taking any investigational drug
  • History of neurologic diseases or impairments
  • Any other factors that the investigators feel would place the patient at increased risk from this study
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02692417


Locations
United States, Michigan
University of Michigan Health System
Ann Arbor, Michigan, United States, 48109
Sponsors and Collaborators
Timothy Bruns
Investigators
Principal Investigator: Timothy Bruns, PhD University of Michigan
Principal Investigator: Mitchell Berger, MD University of Michigan
More Information

Responsible Party: Timothy Bruns, Assistant Professor, University of Michigan
ClinicalTrials.gov Identifier: NCT02692417     History of Changes
Other Study ID Numbers: HUM00101713
First Posted: February 26, 2016    Key Record Dates
Last Update Posted: January 8, 2018
Last Verified: January 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Keywords provided by Timothy Bruns, University of Michigan:
hypoactive desire disorder
female sexual dysfunction
genital arousal disorder
sexual
dysfunction
female
arousal
electrical stimulation
transcutaneous electrical stimulation
women